​

Globus Medical (GMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GMED Stock Forecast

Globus Medical (GMED) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $100.00, with a high of $100.00 and a low of $100.00. This represents a 40.83% increase from the last price of $71.01.

$45 $56 $67 $78 $89 $100 High: $100 Avg: $100 Low: $100 Last Closed Price: $71.01

GMED Stock Rating

Globus Medical stock's rating consensus is Buy, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (73.53%), 8 Hold (23.53%), 1 Sell (2.94%), and 0 Strong Sell (0.00%).

Buy
Total 34 1 8 25 Strong Sell Sell Hold Buy Strong Buy

GMED Price Target Upside V Benchmarks

TypeNameUpside
StockGlobus Medical40.83%
SectorHealthcare Stocks 35.25%
IndustryMedical Device Stocks21.20%

Price Target Trends

1M3M12M
# Anlaysts--6
Avg Price Target--$79.67
Last Closing Price$71.01$71.01$71.01
Upside/Downside--12.20%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25564--15
Mar, 25555--15
Feb, 25555--15
Jan, 25555-116
Dec, 24555-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Kallum TitchmarshMorgan Stanley$100.00$85.5216.93%40.83%
Aug 28, 2024Ryan ZimmermanBTIG$77.00$71.737.35%8.44%
Aug 07, 2024Vik ChopraWells Fargo$78.00$70.5310.59%9.84%
Jul 15, 2024Drew RanieriMorgan Stanley$71.00$71.07-0.10%-0.01%
May 29, 2024Ryan ZimmermanBTIG$72.00$65.499.94%1.39%
May 20, 2024Matt O'BrienPiper Sandler$80.00$64.4024.22%12.66%
Mar 18, 2024Ryan ZimmermanBTIG$60.00$51.6516.17%-15.50%
Sep 19, 2023Mathew BlackmanStifel Nicolaus$61.00$53.0415.01%-14.10%
Jan 06, 2023Morgan Stanley$78.00$71.988.36%9.84%
Dec 20, 2022Truist Financial$85.00$71.3619.11%19.70%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 06, 2024NeedhamHoldHoldhold
Nov 06, 2024Bank of America SecuritiesUnderperformUnderperformhold
Oct 08, 2024RBC CapitalOutperformOutperformhold
Aug 28, 2024BTIGBuyBuyhold
Aug 13, 2024BarclaysOverweightOverweighthold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-Weighthold
May 29, 2024BTIGBuyBuyhold
May 09, 2024BarclaysOverweightOverweighthold
Mar 18, 2024Truist FinancialBuyBuyhold
Mar 18, 2024BTIGBuyupgrade

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.04$1.48$1.89$1.09$0.76----
Avg Forecast$1.36$2.02$2.03$2.31$2.99$3.43$3.93$4.62$4.89
High Forecast$1.37$2.04$2.04$2.34$3.01$3.56$4.55$4.67$4.94
Low Forecast$1.34$2.00$2.02$2.28$2.92$3.24$3.13$4.58$4.84
Surprise %-23.53%-26.73%-6.90%-52.81%-74.58%----

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$789.04M$958.10M$1.02B$1.57B$2.52B----
Avg Forecast$786.87M$951.95M$1.02B$1.56B$2.51B$2.67B$2.85B$3.06B$3.32B
High Forecast$791.54M$957.61M$1.03B$1.57B$2.53B$2.69B$2.85B$3.06B$3.35B
Low Forecast$780.99M$944.84M$1.02B$1.55B$2.50B$2.66B$2.85B$3.05B$3.30B
Surprise %0.28%0.65%-0.20%0.59%0.51%----

Net Income Forecast

$0 $120M $240M $360M $480M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$102.28M$149.19M$190.17M$122.87M$102.98M----
Avg Forecast$46.18M$118.77M$156.07M$122.87M$339.44M$389.74M$466.32M$529.89M$560.54M
High Forecast$75.19M$142.53M$187.28M$147.45M$344.61M$408.46M$521.58M$534.94M$565.80M
Low Forecast$17.16M$95.02M$124.85M$98.30M$334.27M$371.02M$358.42M$524.83M$555.10M
Surprise %121.51%25.61%21.85%--69.66%----

GMED Forecast FAQ

Is Globus Medical stock a buy?

Globus Medical stock has a consensus rating of Buy, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Globus Medical is a favorable investment for most analysts.

What is Globus Medical's price target?

Globus Medical's price target, set by 34 Wall Street analysts, averages $100 over the next 12 months. The price target range spans from $100 at the low end to $100 at the high end, suggesting a potential 40.83% change from the previous closing price of $71.01.

How does Globus Medical stock forecast compare to its benchmarks?

Globus Medical's stock forecast shows a 40.83% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical device stocks industry (21.20%).

What is the breakdown of analyst ratings for Globus Medical over the past three months?

  • April 2025: 33.33% Strong Buy, 40.00% Buy, 26.67% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Globus Medical’s EPS forecast?

Globus Medical's average annual EPS forecast for its fiscal year ending in December 2025 is $3.43, marking a 351.32% increase from the reported $0.76 in 2024. Estimates for the following years are $3.93 in 2026, $4.62 in 2027, and $4.89 in 2028.

What is Globus Medical’s revenue forecast?

Globus Medical's average annual revenue forecast for its fiscal year ending in December 2025 is $2.67B, reflecting a 6.04% increase from the reported $2.52B in 2024. The forecast for 2026 is $2.85B, followed by $3.06B for 2027, and $3.32B for 2028.

What is Globus Medical’s net income forecast?

Globus Medical's net income forecast for the fiscal year ending in December 2025 stands at $389.74M, representing an 278.45% increase from the reported $102.98M in 2024. Projections indicate $466.32M in 2026, $529.89M in 2027, and $560.54M in 2028.